PRQR — ProQR Therapeutics N.V.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1612940 · Netherlands
Last close
$1.15
Market Cap
$162.29M
52W High
$2.48
52W Low
$1.12
ADV30
848,677
Next earnings
2026-11-12

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 8,759,000 — -8,822,000 -8,728,000 133,553,000 117,125,000 54,076,000
Mar 2026 2,033,000 — -13,649,000 -13,383,000 99,034,000 81,088,000 61,436,000
Dec 2025 4,688,000 — -9,097,000 -8,920,000 112,756,000 92,413,000 63,382,000
Sep 2025 2,882,000 — -11,284,000 -11,006,000 124,349,000 106,883,000 67,278,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-49,007,000
Investing CF
$-1,150,000
Financing CF
$47,233,000
CapEx
$-1,150,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.45
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-487,412,000
Inventory
—
Receivables
$4,505,000
ST Investments
—
EBIT TTM
$-40,642,000
Pretax Income TTM
$-42,011,000
Interest Exp TTM
—
Analysts
9

Yahoo Snapshot (yfinance, live)

Total Revenue
$18,423,000
EBITDA
$-41,902,000
Free Cash Flow
$-19,073,124
Enterprise Value
$102,710,024
Total Cash
$117,125,000
Total Debt
$15,312,000
Shares Out
141,119,032
Trailing EPS
$-0.47
Book Value
$0.84
ROE
-57.4%
ROA
-19.8%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 15,906,000 -43,446,000 -42,184,000 112,756,000 63,382,000 49,374,000 -52,791,000
Dec 2024 18,905,000 -30,472,000 -27,763,000 167,958,000 79,398,000 88,560,000 -36,393,000
Dec 2023 6,514,000 -34,790,000 -28,119,000 137,883,000 96,493,000 41,390,000 21,548,000
Dec 2022 3,594,000 -65,159,000 -64,424,000 171,321,000 104,640,000 67,065,000 -68,508,000

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.47

Max Pain — expiry 2027-04-16

max pain strike: $1.50 · spot: $1.10 · call oi: 1,478 · put oi: 61

Peers — same industry

TickerNameMarket CapLastDaily %
BCYC BICYCLE THERAPEUTICS PLC $162.10M $3.20 —
YARW Yarrow Bioscience, Inc. $163.04M $14.21 —
ANTX AN2 Therapeutics, Inc. $160.50M $4.23 —
ABEO ABEONA THERAPEUTICS INC. $160.27M $2.60 —
ELDN Eledon Pharmaceuticals, Inc. $167.23M $1.98 —

News headlines (Yahoo Finance, 1h cache)

ProQR Announces Third Quarter 2026 Operating and Financial Results
2026-11-12 12:00 · Yahoo
ProQR to Present Clinical and Preclinical Progress from AX-0810 and AX-0811 at Upcoming Conferences
2026-10-28 12:00 · Yahoo
ProQR Reports First Human Validation of RNA Editing Platform in Liver Disease
2026-10-02 08:02 · Yahoo
ProQR Announces Appointment of Chris Hart as Chief Data and AI Officer and Thomas Wolf to join the Board of Directors as Strategic AI Advisor
2026-09-23 12:00 · Yahoo
ProQR to Participate in Upcoming Investor Conferences in September 2026
2026-09-02 12:00 · Yahoo
ProQR Announces Positive Phase 1 Target Engagement Data for AX-0810, Establishing First Clinical Validation of the Axiomer RNA Editing Platform
2026-06-25 10:25 · Yahoo
ProQR Prices $50.0 Million Underwritten Registered Direct Offering and Concurrent Private Placement
2026-06-25 10:35 · Yahoo
ProQR Announces First Quarter 2026 Operating and Financial Results
2026-05-12 11:00 · Yahoo
ProQR Announces Multiple Upcoming Scientific Conference Presentations Highlighting the Breadth of its Axiomer™ RNA Editing Platform
2026-05-11 12:00 · Yahoo
ProQR Therapeutics N.V. (NASDAQ:PRQR) Analysts Just Slashed This Year's Revenue Estimates By 22%
2026-05-14 12:25 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.